JP Morgan Chase’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $65.8K | Buy |
|
|||||
|
2023
Q4 | $149 | Sell |
|
|||||
|
2023
Q3 | $12.4K | Buy |
|
|||||
|
2023
Q2 | $4.65K | Sell |
|
|||||
|
2023
Q1 | $149K | Buy |
|
|||||
|
2022
Q4 | $109K | Sell |
|
|||||
|
2022
Q3 | $228K | Buy |
|
|||||
|
2022
Q2 | $221K | Sell |
|
|||||
|
2022
Q1 | $246K | Buy |
|
|||||
|
2021
Q4 | $321K | Buy |
|
|||||
|
2021
Q3 | $309K | Buy |
|
|||||
|
2021
Q2 | $189K | Buy |
|
|||||
|
2021
Q1 | $158K | Buy |
|